Sorry, you need to enable JavaScript to visit this website.

All materials and content available on the website are of strictly non-promotional nature and only intended for healthcare professionals (HCPs) practicing in Europe. Kindly note that materials and content are not intended for any specific country and approval conditions for products may vary from country to country. Before prescribing any product, always refer to the approved label in the relevant country and/or the Summary of Product Characteristics.

  • ANCA-associated vasculitis

GC tapering for patients receiving avacopan

Explore the science
  • IgA Nephropathy

Innovative approaches to IgAN therapy: Summary presentation from Prof. Huynh Do

Explore the science
  • ANCA-associated vasculitis

Mehr Kontrolle, weniger Belastung: Moderne Ansätze in der Behandlung der ANCA – assoziierten Vaskulitiden (GPA/MPA): Vortrag vom PD. Dr. C. Iking-Konert, Zürich

Explore the science
  • ANCA-associated vasculitis

ANCA-Vaskulitis : auf dem Weg zu besserer Kontrolle

Explore the science
  • ANCA-associated vasculitis

Vascularite associée aux ANCA : vers un meilleur contrôle

Explore the science
  • ANCA-associated vasculitis

BVAS-Aktivitätsmessung der Vaskulitis in der klinischen Praxis – Interaktiver Workshop

Explore the science
  • Menopause

Swiss expert guide to hormone replacement therapy for menopause

Explore the science
  • Vaccines

Economic justification of cell culture-based influenza vaccines in children and adults: a review of cost-effectiveness analyses

Explore the science
  • Glomerular Disease

A conversation with Prof. Dr. Jörg Latus and Sydney Tang on new therapy options in IgA nephropathy

Explore the science